A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
Carmen Riggioni(Hospital Sant Joan de Déu Barcelona), Cezmi A. Akdiş(University of Zurich)
Cited by 150
Related Papers
Risk factors for severe and critically ill COVID‐19 patients: A review
|Allergy|2020|1.4k
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
|Allergy|2020|1.2k
Role of interleukin 10 in specific immunotherapy.
|Journal of Clinical Investigation|1998|968
Mechanisms and treatment of allergic disease in the big picture of regulatory T cells
|Journal of Allergy and Clinical Immunology|2009|332
Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
|Journal of Clinical Investigation|2019|300